AlphaFold predicted structure
CD96 · P40200

Mean pLDDT
64.9/ 100
Low
585 residues
Confidence breakdown
- Very high(≥ 90)19%
- Confident(70–90)32%
- Low(50–70)17%
- Very low(< 50)32%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
CD96 molecule
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Fetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownLimb disorders
Rare syndromic craniosynostosis or isolated multisuture synostosis
Skeletal dysplasia
C syndrome
tooth disorder
diaphragm disorder
Abnormal erythrocyte morphology
lacrimal apparatus disorder
adolescent idiopathic scoliosis
response to TNF antagonist
neoplasm
acute myeloid leukemia
central nervous system cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
T-cell surface protein tactile
May be involved in adhesive interactions of activated T and NK cells during the late phase of the immune response. Promotes NK cell-target adhesion by interacting with PVR present on target cells. May function at a time after T and NK cells have penetrated the endothelium using integrins and selectins, when they are actively engaging diseased cells and moving within areas of inflammation
CD96 · P40200

Mean pLDDT
64.9/ 100
Low
585 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0